Anika Therapeutics, Inc.

ANIKNASDAQHealthcare● Active

$14.60

+$0.12(+0.83%)

Market Cap$194262110

P/E Ratio—

52W High$16.24

52W Low$7.87

Avg Volume114K

Open$14.65

Beta0.23

Forecast Market Cap PE Ratio

Anika Therapeutics, Inc.（ANIK）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

anik · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 6 位华尔街分析师

Buy

6 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 6 · 买入占比: 50.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $14.60

Anika Therapeutics, Inc.（ANIK）的分析师共识为 Buy，基于过去 3 个月内 6 位华尔街分析师的评级。ANIK 的 12 个月平均目标价为 $0.00，相对当前价 $14.60 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$14.44	↓ 1.07%	$14.30	$14.58

1-day model range: $14.3–$14.58. Peak: $14.58 (-1.07%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$14	$15	$16	+3.2%
2028	$14	$15	$16	+4.9%
2029	$14	$15	$17	+5.7%
2030	$14	$16	$17	+6.2%
2031	$14	—	$17	+6.4%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%

7Buy

1Neutral

6Sell

RSI (14)42.9Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ANIK · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$14.53BUY

MA 10$14.64SELL

MA 20$14.78SELL

MA 50$14.85SELL

MA 100$13.31BUY

MA 200$11.36BUY

Current $ANIK · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$14.58BUY

EMA 10$14.64SELL

EMA 20$14.71SELL

EMA 50$14.47BUY

EMA 100$13.57BUY

EMA 200$12.87BUY

Current $ANIK · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-02-27	Barrington Research	Maintains	Outperform→Outperform
2026-01-09	Barrington Research	Maintains	Outperform→Outperform
2025-11-06	Barrington Research	Maintains	Outperform→Outperform
2025-09-23	Barrington Research	Maintains	Outperform→Outperform
2025-07-31	Barrington Research	Maintains	Outperform→Outperform
2025-05-12	Barrington Research	Maintains	Outperform→Outperform
2025-03-13	Barrington Research	Maintains	Outperform→Outperform
2024-11-01	Barrington Research	Maintains	Outperform→Outperform
2024-10-22	Barrington Research	Maintains	Outperform→Outperform
2024-08-09	Barrington Research	Maintains	Outperform→Outperform

Barrington Research2026-02-27

Maintains

Outperform→Outperform

Barrington Research2026-01-09

Maintains

Outperform→Outperform

Barrington Research2025-11-06

Maintains

Outperform→Outperform

Barrington Research2025-09-23

Maintains

Outperform→Outperform

Barrington Research2025-07-31

Maintains

Outperform→Outperform

Barrington Research2025-05-12

Maintains

Outperform→Outperform

Barrington Research2025-03-13

Maintains

Outperform→Outperform

Barrington Research2024-11-01

Maintains

Outperform→Outperform

Barrington Research2024-10-22

Maintains

Outperform→Outperform

Barrington Research2024-08-09

Maintains

Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Anika Therapeutics, Inc. (ANIK) stock. Of the recent 35 rating actions, 7 were upgrades and 8 were downgrades. 6 analysts currently cover ANIK.

分析师推荐趋势

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

ANIK analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$150M

↑ 26.6% YoY

Revenue Next Year

$111M

↓ 26.1% YoY

EPS This Year

$0.10

EPS Next Year

$-0.61

↓ 715.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ANIK EPS of $0.10 for the current fiscal year, based on estimates from 1 analysts. The ANIK revenue forecast is $150M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ANIK 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ANIK 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

ANIK 的短期预测（明日）为 $14.44（-1.07%）。 ANIK 对 2027 年的股价预测均值为 $15。 ANIK 对 2030 年的预测区间为 $14–$17。

Anika Therapeutics, Inc. 在 NASDAQ 上市，代码 ANIK。ANIK 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ANIK 预测 · 8 个问题

根据 6 位华尔街分析师，ANIK 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $14.60，隐含约 +0.0% 的上行空间。

ANIK 目标价ANIK 分析师目标价ANIK 12个月目标价目标价 ANIK

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.